Cite
HARVARD Citation
Lin, N. et al. (2021). Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study. Journal of clinical oncology. 39 (24), pp. 2667-2675. [Online].